TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in TFF Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TFFP is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 1
- 0 vs. Q3 2025
- Shares held
- 40.0K
- 0 (0.0%) vs. Q3 2025
- Total value
- $0
- $0 vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TFFP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 3 | $0 |
| Q4 2024 | 4 | $196 |
| Q3 2024 | 23 | $1.48M |
| Q2 2024 | 21 | $1.07M |
| Q1 2024 | 19 | $2.12M |
| Q4 2023 | 23 | $2.45M |
| Q3 2023 | 41 | $4.04M |
| Q2 2023 | 33 | $3.02M |
| Q1 2023 | 36 | $4.80M |
| Q4 2022 | 41 | $7.52M |
| Q3 2022 | 45 | $17.2M |
| Q2 2022 | 45 | $23.7M |
| Q1 2022 | 43 | $27.1M |
| Q4 2021 | 51 | $41.1M |
| Q3 2021 | 54 | $45.1M |
| Q2 2021 | 60 | $54.5M |
| Q1 2021 | 63 | $96.1M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding TFF Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 40,000 | $0 | 0.00% | 00.0% | Unchanged |